Showing results (61-70 of 109) with videos related to

Sort By:
Pageof 11
Clinical Spine Surgery|March 16, 2024
AM-PAC Mobility Score <13 Predicts Development of Ileus Following Adult Spinal Deformity SurgeryJarod Olson, Kevin C Mo, Jessica Schmerler, et al.
Spine Deformity|June 24, 2022
Preoperative duration of pain is associated with chronic opioid use after adult spinal deformity surgeryKevin C Mo, Rahul Sachdev, Bo Zhang, et al.
Expert Review of Hematology|May 14, 2021
Selinexor for the treatment of patients with previously treated multiple myelomaClifton C Mo, Sundar Jagannath, Ajai Chari, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2004
Disruption of the Candida albicans CYB5 gene results in increased azole sensitivityK M Rogers, C A Pierson, N T Culbertson, et al.
The Spine Journal : Official Journal of the North American Spine Society|April 26, 2023
Pain Self-Efficacy (PSEQ) score of <22 is associated with daily opioid use, back pain, disability, and PROMIS scores in patients presenting for spine surgeryKevin C Mo, Arjun Gupta, Jonathan Movsik, et al.
Haematologica|May 30, 2013
Rapid clearance of rituximab may contribute to the continued high incidence of autoimmune hematologic complications of chemoimmunotherapy for chronic lymphocytic leukemiaClifton C Mo, Ndegwa Njuguna, Paul V Beum, et al.
Spine|August 2, 2023
Abnormal Postoperative PROMIS Scores are Associated With Patient Satisfaction in Adult Spinal Deformity and Degenerative Spine PatientsOscar Covarrubias, Nicholas S Andrade, Kevin C Mo, et al.
Expert Opinion on Drug Safety|October 31, 2023
A safety review of recently approved and emerging drugs for patients with relapsed or refractory multiple myelomaShonali Midha, Monique A Hartley-Brown, Clifton C Mo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 3, 2019
Health concerns of cancer survivors after primary anti-cancer treatmentS Y Tan, J Turner, K Kerin-Ayres, et al.
Ejhaem|August 21, 2023
Selinexor: Targeting a novel pathway in multiple myelomaClifton C Mo, Andrew J Yee, Shonali Midha, et al.
Pageof 11